Kelly A. Romano - Jun 21, 2024 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
/s/ Mark Worthington, Attorney in fact for Kelly A. Romano
Stock symbol
ATHA
Transactions as of
Jun 21, 2024
Transactions value $
$100,051
Form type
4
Date filed
6/25/2024, 07:21 PM
Previous filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Purchase $33.9K +15K +39.15% $2.26 53.3K Jun 21, 2024 Direct F1
transaction ATHA Common Stock Purchase $66.2K +27.4K +51.39% $2.42 80.7K Jun 24, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
F2 The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.39 to $2.43, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.